HYEX
Healthy Extracts Inc.
Price Chart
Latest Quote
$2.15
| Previous Close | $2.70 |
| Open | $2.15 |
| Day High | $2.15 |
| Day Low | $2.15 |
| Volume | 930 |
Stock Information
| Shares Outstanding | 14.73M |
| Total Debt | $2.56M |
| Cash Equivalents | $164K |
| Revenue | $5.19M |
| Net Income | $-683K |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $31.67M |
| P/E Ratio | 71.67 |
| EPS (TTM) | $0.03 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $38.71M |
| Sales | $5.19M |
| Income | $-683K |
| Book/sh | $1.42 |
| Cash/sh | $0.01 |
| Employees | 22 |
Financial Ratios
| Quick Ratio | 0.26 |
| Current Ratio | 0.69 |
| Debt/Eq | 10.66 |
Returns & Margins
| ROA | -4.89% |
| ROE | -5.68% |
| Gross Margin | 57.52% |
| Operating Margin | -20.41% |
| Profit Margin | -13.15% |
Ownership
| Insider Ownership | 80.53% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 16.54 |
| P/S | 6.10 |
| P/B | 1.51 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $2.53 |
| SMA50 | $1.84 |
| SMA200 | $1.93 |
| RSI | 6.80 |
| ATR | 0.0422 |
| Shares Float | 3.29M |
| Volatility | -0.79 |
| Rel Volume | 2.86 |
Performance History
| Week | -20.37% |
| Month | +90.27% |
| Quarter | +36.08% |
| 6 Months | +12.56% |
| YTD | +41.45% |
| Year | +36.94% |
| 3 Years | -66.19% |
| 5 Years | -77.03% |
| 10 Years | -99.97% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $2.15 | 930 |
| 2026-06-23 | $2.70 | 0 |
| 2026-06-22 | $2.70 | 116 |
| 2026-06-18 | $2.70 | 0 |
| 2026-06-17 | $2.70 | 0 |
| 2026-06-16 | $2.70 | 0 |
| 2026-06-15 | $2.70 | 0 |
| 2026-06-12 | $2.70 | 0 |
| 2026-06-11 | $2.70 | 0 |
| 2026-06-10 | $2.70 | 0 |
| 2026-06-09 | $2.70 | 300 |
| 2026-06-08 | $2.66 | 0 |
| 2026-06-05 | $2.66 | 0 |
| 2026-06-04 | $2.66 | 0 |
| 2026-06-03 | $2.66 | 0 |
| 2026-06-02 | $2.66 | 578 |
| 2026-06-01 | $2.60 | 1,185 |
| 2026-05-29 | $2.25 | 1,000 |
| 2026-05-28 | $1.93 | 1,500 |
| 2026-05-27 | $1.32 | 900 |
| 2026-05-26 | $1.13 | 0 |
About Healthy Extracts Inc.
Healthy Extracts Inc., through its subsidiaries, engages in acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals in the United States. It operates through Corporate and Health Supplements segments. The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health. It also provides heart and immune health products, including bergamot-based products in tablet and capsule form; and plant-based health technology neuro-products that enhance brain health comprising memory, cognition, focus, and neuro-energy. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is headquartered in Henderson, Nevada.
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,201,959 | $864,055 | $879,951 | $981,520 |
| Cost Of Revenue | $1,201,959 | $864,055 | $879,951 | $981,520 |
| Total Revenue | $3,113,279 | $2,485,866 | $2,251,469 | $1,676,598 |
| Operating Revenue | $3,113,279 | $2,485,866 | $2,251,469 | $1,676,598 |
| Expenses | ||||
| Total Expenses | $3,296,428 | $4,729,709 | $3,163,058 | $3,565,776 |
| Other Income Expense | $-471,270 | $-52,140 | $-6,841 | $-45,492 |
| Net Non Operating Interest Income Expense | $-186,252 | $-176,948 | $-64,690 | $-52,453 |
| Total Other Finance Cost | $186,252 | $176,948 | $64,690 | $52,453 |
| Operating Expense | $2,094,469 | $3,865,654 | $2,283,107 | $2,584,256 |
| Selling And Marketing Expense | $697,533 | - | - | - |
| General And Administrative Expense | $1,396,936 | $3,865,654 | $2,283,107 | $2,584,256 |
| Interest Expense | - | - | - | $52,453 |
| Interest Expense Non Operating | - | - | - | $52,453 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-840,671 | $-2,472,931 | $-983,121 | $-1,987,122 |
| Net Interest Income | $-186,252 | $-176,948 | $-64,690 | $-52,453 |
| Normalized Income | $-369,401 | $-2,420,791 | $-976,280 | $-1,941,630 |
| Net Income From Continuing And Discontinued Operation | $-840,671 | $-2,472,931 | $-983,121 | $-1,987,122 |
| Net Income Common Stockholders | $-840,671 | $-2,472,931 | $-983,121 | $-1,987,122 |
| Net Income | $-840,671 | $-2,472,931 | $-983,121 | $-1,987,122 |
| Net Income Including Noncontrolling Interests | $-840,671 | $-2,472,931 | $-983,121 | $-1,987,122 |
| Net Income Continuous Operations | $-840,671 | $-2,472,931 | $-983,121 | $-1,987,122 |
| Pretax Income | $-840,671 | $-2,472,931 | $-983,121 | $-1,987,122 |
| Operating Income | $-183,149 | $-2,243,844 | $-911,590 | $-1,889,178 |
| Gross Profit | $1,911,320 | $1,621,810 | $1,371,517 | $695,078 |
| Special Income Charges | - | $0 | $2,643 | $39,833 |
| Per Share | ||||
| Diluted EPS | $-0.28 | $-0.85 | $-0.34 | $-1.20 |
| Basic EPS | $-0.28 | $-0.85 | $-0.34 | $-1.20 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $288,121 | $-2,189,509 | $-903,871 | $-1,838,586 |
| Total Unusual Items | $-471,270 | $-52,140 | $-6,841 | $-45,492 |
| Total Unusual Items Excluding Goodwill | $-471,270 | $-52,140 | $-6,841 | $-45,492 |
| Reconciled Depreciation | $-139 | $2,195 | $878 | $5,100 |
| EBITDA (Bullshit earnings) | $-183,149 | $-2,241,649 | $-910,712 | $-1,884,078 |
| EBIT | $-183,149 | $-2,243,844 | $-911,590 | $-1,889,178 |
| Diluted Average Shares | $2,978,540 | $2,915,410 | $2,854,290 | $2,660,082 |
| Basic Average Shares | $2,978,540 | $2,915,410 | $2,854,290 | $2,660,082 |
| Diluted NI Availto Com Stockholders | $-840,671 | $-2,472,931 | $-983,121 | $-1,987,122 |
| Gain On Sale Of Security | $-471,270 | $-52,140 | $-9,484 | $-85,325 |
| Selling General And Administration | $2,094,469 | $3,865,654 | $2,283,107 | $2,584,256 |
| Other Gand A | $963,878 | $2,172,909 | $2,283,107 | $2,584,256 |
| Salaries And Wages | $433,058 | $1,692,745 | - | - |
| Gain On Sale Of Ppe | - | $0 | $2,643 | $0 |
| Write Off | - | $0 | $0 | - |
| Other Special Charges | - | - | - | $-39,833 |
| Impairment Of Capital Assets | - | - | - | $0 |
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-304,764 | $239,448 | $1,163,188 | $1,755,597 |
| Total Assets | $2,377,973 | $2,635,014 | $2,781,118 | $3,029,579 |
| Total Non Current Assets | $718,586 | $735,336 | $737,531 | $716,175 |
| Non Current Prepaid Assets | $0 | $16,890 | $16,890 | $0 |
| Goodwill And Other Intangible Assets | $715,141 | $715,141 | $715,141 | $715,141 |
| Other Intangible Assets | $521,881 | $521,881 | $521,881 | $521,881 |
| Current Assets | $1,659,387 | $1,899,678 | $2,043,587 | $2,313,404 |
| Other Current Assets | $8,984 | $71,583 | $-1 | - |
| Current Deferred Assets | $149,274 | $151,931 | $0 | - |
| Prepaid Assets | $16,890 | $0 | $53,015 | - |
| Inventory | $1,361,216 | $1,626,283 | $1,819,128 | $1,957,966 |
| Receivables | $11,003 | $30,440 | $105,794 | $133,340 |
| Accounts Receivable | $11,003 | $30,440 | $105,794 | $133,340 |
| Cash Cash Equivalents And Short Term Investments | $112,020 | $19,441 | $65,651 | $222,098 |
| Cash And Cash Equivalents | $112,020 | $19,441 | $65,651 | $222,098 |
| Cash Financial | $112,020 | $19,441 | $65,651 | $222,098 |
| Other Non Current Assets | - | $-1 | $-1 | $-1 |
| Debt | ||||
| Net Debt | $820,655 | $1,033,619 | $527,869 | $120,518 |
| Total Debt | $941,897 | $1,127,511 | $593,520 | $342,616 |
| Current Debt And Capital Lease Obligation | $941,897 | $1,127,511 | $593,520 | $342,616 |
| Current Debt | $932,675 | $1,053,060 | $593,520 | $342,616 |
| Other Current Borrowings | $531,526 | $609,467 | $318,150 | $171,750 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,967,596 | $1,680,425 | $902,789 | $558,841 |
| Total Non Current Liabilities Net Minority Interest | $0 | $1 | $1 | $0 |
| Current Liabilities | $1,967,596 | $1,680,424 | $902,788 | $558,841 |
| Other Current Liabilities | $625,420 | $154,151 | $102,011 | $92,526 |
| Current Notes Payable | $2,427 | $361,093 | $275,370 | $170,866 |
| Payables And Accrued Expenses | $400,279 | $398,762 | $207,257 | $123,699 |
| Interest Payable | $99,422 | $66,851 | $21,387 | $27,168 |
| Payables | $52,248 | $116,842 | $91,316 | $37,267 |
| Accounts Payable | $52,248 | $116,842 | $91,316 | $37,267 |
| Equity | ||||
| Common Stock Equity | $410,377 | $954,589 | $1,878,329 | $2,470,738 |
| Total Equity Gross Minority Interest | $410,377 | $954,589 | $1,878,329 | $2,470,738 |
| Stockholders Equity | $410,377 | $954,589 | $1,878,329 | $2,470,738 |
| Retained Earnings | $-19,240,344 | $-18,399,673 | $-15,926,742 | $-14,943,620 |
| Other | ||||
| Treasury Shares Number | $4,166 | - | - | - |
| Ordinary Shares Number | $2,989,406 | $2,954,104 | $2,876,437 | $2,819,868 |
| Share Issued | $2,993,572 | $2,954,104 | $2,876,437 | $2,819,868 |
| Tangible Book Value | $-304,764 | $239,448 | $1,163,188 | $1,755,597 |
| Invested Capital | $1,343,052 | $2,007,649 | $2,471,849 | $2,813,354 |
| Working Capital | $-308,209 | $219,254 | $1,140,799 | $1,754,563 |
| Capital Lease Obligations | $9,222 | $74,451 | $0 | - |
| Total Capitalization | $410,377 | $954,589 | $1,878,329 | $2,470,738 |
| Treasury Stock | $5,400 | $0 | - | - |
| Additional Paid In Capital | $19,301,589 | $18,999,770 | $17,459,899 | $17,075,974 |
| Capital Stock | $354,532 | $354,492 | $345,172 | $338,384 |
| Common Stock | $354,532 | $354,492 | $345,172 | $338,384 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Capital Lease Obligation | $9,222 | $74,451 | $0 | - |
| Line Of Credit | $398,722 | $82,500 | - | - |
| Current Accrued Expenses | $348,031 | $281,920 | $115,941 | $86,432 |
| Goodwill | $193,260 | $193,260 | $193,260 | $193,260 |
| Net PPE | $3,445 | $3,306 | $5,501 | $1,035 |
| Gross PPE | $3,445 | $3,306 | $5,501 | $46,979 |
| Other Properties | $3,445 | $3,306 | $5,501 | - |
| Inventories Adjustments Allowances | $-781,759 | $-1,611,257 | - | $-1,914,891 |
| Other Inventories | $-300 | - | - | $3,872,857 |
| Finished Goods | $186,938 | $225,567 | $310,600 | $194,490 |
| Work In Process | $23,954 | $13,290 | $24,764 | $5,668 |
| Raw Materials | $1,932,383 | $2,998,683 | $1,483,764 | $1,757,808 |
| Accumulated Depreciation | - | - | $-44,709 | $-45,944 |
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $281,968 | $-415,749 | $-398,608 | $-997,302 |
| Operating Activities | ||||
| Operating Cash Flow | $281,968 | $-415,749 | $-390,621 | $-901,298 |
| Cash Flow From Continuing Operating Activities | $281,970 | $-415,750 | $-390,621 | $-901,298 |
| Operating Gains Losses | $773,128 | $1,691,331 | $411,584 | $694,161 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $0 | $-5,344 | $-96,004 |
| Cash Flow From Continuing Investing Activities | - | $0 | $-5,344 | $-96,004 |
| Capital Expenditure | - | - | $-7,987 | $-96,004 |
| Net Other Investing Changes | - | - | $2,643 | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-5,400 | $-90,000 | $-11,386 | - |
| Financing Cash Flow | $-189,389 | $369,539 | $239,518 | $1,160,199 |
| Cash Flow From Continuing Financing Activities | $-189,389 | $369,539 | $239,519 | $1,160,199 |
| Net Common Stock Issuance | $-5,400 | $-90,000 | $-11,386 | $995,199 |
| Net Other Financing Charges | - | $68,888 | $-1 | - |
| Issuance Of Capital Stock | - | - | - | $995,199 |
| Common Stock Issuance | - | - | - | $995,199 |
| Other | ||||
| Repayment Of Debt | $-592,789 | $-793,095 | $-488,095 | $0 |
| Issuance Of Debt | $408,800 | $1,183,746 | $739,000 | $165,000 |
| End Cash Position | $112,020 | $19,441 | $65,651 | $222,098 |
| Beginning Cash Position | $19,441 | $65,651 | $222,098 | $59,201 |
| Changes In Cash | $92,579 | $-46,210 | $-156,447 | $162,897 |
| Common Stock Payments | $-5,400 | $-90,000 | $-11,386 | - |
| Net Issuance Payments Of Debt | $-183,989 | $390,651 | $250,905 | $165,000 |
| Net Short Term Debt Issuance | $408,800 | $820,783 | $275,370 | $0 |
| Short Term Debt Issuance | $408,800 | $820,783 | $275,370 | $0 |
| Net Long Term Debt Issuance | $-592,789 | $-430,132 | $-24,465 | $165,000 |
| Long Term Debt Payments | $-592,789 | $-793,095 | $-488,095 | $0 |
| Long Term Debt Issuance | $0 | $362,963 | $463,630 | $165,000 |
| Change In Working Capital | $313,104 | $363,655 | $180,038 | $386,563 |
| Change In Other Working Capital | $2,657 | $-98,916 | $-53,015 | - |
| Change In Other Current Liabilities | $-65,229 | $74,451 | $0 | - |
| Change In Other Current Assets | $62,599 | $-71,583 | $0 | - |
| Change In Payables And Accrued Expense | $28,573 | $191,505 | $83,558 | $46,912 |
| Change In Accrued Expense | $93,168 | $165,979 | $29,510 | $74,481 |
| Change In Interest Payable | $59,628 | $45,464 | $-5,781 | $24,271 |
| Change In Payable | $-64,595 | $25,526 | $54,048 | $-27,569 |
| Change In Account Payable | $-64,595 | $25,526 | $54,048 | $-27,569 |
| Change In Inventory | $265,067 | $192,845 | $138,838 | $459,717 |
| Change In Receivables | $19,437 | $75,353 | $27,547 | $-120,066 |
| Changes In Account Receivables | $19,437 | $75,353 | $27,547 | $-120,066 |
| Other Non Cash Items | $36,546 | $1 | $-1 | - |
| Depreciation Amortization Depletion | $-139 | $2,195 | $878 | $5,100 |
| Depreciation And Amortization | $-139 | $2,195 | $878 | $5,100 |
| Gain Loss On Investment Securities | $773,128 | $1,691,331 | $411,584 | $694,161 |
| Net Income From Continuing Operations | $-840,671 | $-2,472,931 | $-983,121 | $-1,987,122 |
| Net PPE Purchase And Sale | - | $0 | $-7,987 | $0 |
| Purchase Of PPE | - | $0 | $-7,987 | $0 |
| Change In Prepaid Assets | - | $0 | $-16,890 | $0 |
| Net Business Purchase And Sale | - | - | $0 | $0 |
| Sale Of Business | - | - | $0 | $0 |
| Net Intangibles Purchase And Sale | - | - | $0 | $-96,004 |
| Stock Based Compensation | - | - | $0 | $0 |
| Asset Impairment Charge | - | - | $0 | $0 |
| Short Term Debt Payments | - | - | - | $0 |
| Purchase Of Business | - | - | - | $0 |